Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$119.39 USD

119.39
6,741,790

+1.50 (1.27%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $119.40 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Why Abbott (ABT) is Poised to Beat Earnings Estimates Again

by Zacks Equity Research

Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Abbott (ABT) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $111.80, marking a +0.26% move from the previous day.

The Zacks Analyst Blog Highlights Pfizer, Abbott Laboratories, Union Pacific Corporation, Citigroup and Intuitive Surgical.

by Zacks Equity Research

Pfizer, Abbott Laboratories, Union Pacific Corporation, Citigroup and Intuitive Surgical are part of the Zacks top Analyst Blog.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

by Zacks Equity Research

Sector ETF report for IHI

Sheraz Mian headshot

Top Analyst Reports for Pfizer, Abbott Laboratories & Union Pacific

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Abbott Laboratories (ABT) and Union Pacific Corporation (UNP).

Analysts Estimate Abbott (ABT) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for Abbott Laboratories (ABT) in Q4 Earnings?

by Zacks Equity Research

Within Abbott's (ABT) Established Pharmaceuticals Division (EPD), new product launches across key markets have been majorly boosting business in recent months.

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $111.36, marking a -1.58% move from the previous day.

Abbott's (ABT) New Launch to Boost Blood Donation Experience

by Zacks Equity Research

Abbott's (ABT) mixed reality offers donors an innovative, immersive digital experience while giving blood.

Abbott (ABT) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed the most recent trading day at $112.33, moving +1.38% from the previous trading session.

Abbott (ABT) Stock Moves -0.19%: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $109.58, marking a -0.19% move from the previous day.

Abbott (ABT) to Upgrade PHCs Across India With New Pact

by Zacks Equity Research

Abbott's (ABT) HWC program is likely to benefit more than 2.5 million people from under-resourced communities annually.

Abbott (ABT) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $108.57, marking a +0.36% move from the previous day.

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Abbott's (ABT) FreeStyle Libre 3 Integrates With AID System

by Zacks Equity Research

Abbott's (ABT) FreeStyle Libre 3 integration with mylife Loop solutions will help build a smart, automated process to deliver insulin based on real-time glucose data.

Here's Why You Should Retain Abbott (ABT) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Abbott (ABT) owing to the strength in its Diabetes business and product launches.

Abbott's (ABT) Eterna SCS System Receives FDA's Approval

by Zacks Equity Research

Abbott's (ABT) Eterna SCS technology shows 23% more pain reduction compared with traditional waveform technology approaches.

Abbott (ABT) Stock Moves -0.3%: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $106.59, marking a -0.3% move from the previous day.

Sheraz Mian headshot

Top Research Reports for Berkshire Hathaway, Exxon Mobil & Pfizer

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BR.B), Exxon Mobil Corporation (XOM) and Pfizer Inc. (PFE).

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $111.53, marking a +1.86% move from the previous day.

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

by Zacks Equity Research

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Abbott (ABT) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed the most recent trading day at $104.81, moving +0.91% from the previous trading session.

Abbott (ABT) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed at $107.93 in the latest trading session, marking a +0.33% move from the prior day.

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

by Zacks Equity Research

Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.